Agenus (AGEN) Change in Accured Expenses (2010 - 2026)
Agenus' (AGEN) quarterly Change in Accured Expenses came in at -$3.1 million in Q1 2026, down 323.35% year-on-year from $1.4 million in Q1 2025, and up 65.53% quarter-over-quarter from -$8.9 million in Q4 2025.
Agenus (AGEN) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Agenus' Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$3.1 million for Q1 2026.
- On a quarterly basis, Change in Accured Expenses fell 323.35% year-over-year to -$3.1 million in Q1 2026; TTM through Mar 2026 was $40000.0, a 99.22% decrease from a year earlier, with the FY2025 full-year figure at $4.5 million, up 3208.09% from the prior year.
- Change in Accured Expenses advanced to -$3.1 million in Q1 2026 per AGEN's latest filing, from -$8.9 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $9.2 million in Q3 2025 and bottomed at -$8.9 million in Q4 2025.
- The 5-year median for Change in Accured Expenses is $2.1 million (2024), against an average of $1.4 million.
- Across the five-year window, Change in Accured Expenses surged 1748.75% in 2023 and tumbled 463.43% in 2025, its largest moves.
- Year by year, Change in Accured Expenses stood at $4.6 million in 2022, then jumped by 77.6% to $8.1 million in 2023, then plunged by 119.59% to -$1.6 million in 2024, then tumbled by 463.43% to -$8.9 million in 2025, then soared by 65.53% to -$3.1 million in 2026.
- Per Business Quant, the three latest AGEN Change in Accured Expenses figures stand at -$3.1 million (Q1 2026), -$8.9 million (Q4 2025), and $9.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 931,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -16.82 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -16.74 Mn |
| 10 | Agenus | 234.10 Mn | 199.10 Mn | 33.74 Mn | -3.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.08 Mn |
| Mar 31, 2026 | -3.08 Mn |
| Dec 31, 2025 | -8.94 Mn |
| Dec 31, 2025 | -8.94 Mn |
| Sep 30, 2025 | 9.21 Mn |
| Sep 30, 2025 | 9.21 Mn |
| Jun 30, 2025 | 2.85 Mn |
| Jun 30, 2025 | 2.85 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | -1.59 Mn |
| Dec 31, 2024 | -1.59 Mn |
| Sep 30, 2024 | 2.11 Mn |
| Sep 30, 2024 | 2.11 Mn |
| Jun 30, 2024 | 3.24 Mn |
| Jun 30, 2024 | 3.24 Mn |
| Mar 31, 2024 | -3.62 Mn |
| Mar 31, 2024 | -3.62 Mn |
| Dec 31, 2023 | 8.10 Mn |
| Dec 31, 2023 | 8.10 Mn |